Limited hepatitis B immunoglobulin with potent nucleos(t)ide analogue is a cost-effective prophylaxis against hepatitis B virus after liver transplantation.
- DOI
- 10.1016/j.transproceed.2014.11.029
- Published
- 2015 Mar
- Container
- Transplantation proceedings
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.transproceed.2014.11.029,
title = {Limited hepatitis B immunoglobulin with potent nucleos(t)ide analogue is a cost-effective prophylaxis against hepatitis B virus after liver transplantation.},
author = {Singer GA and Zielsdorf S and Fleetwood VA and Alvey N and Cohen E and Eswaran S and Shah N and Chan EY and Hertl M and Fayek SA},
year = {2015},
journal = {Transplantation proceedings},
doi = {10.1016/j.transproceed.2014.11.029},
url = {https://doi.org/10.1016/j.transproceed.2014.11.029}
}RIS
TY - JOUR TI - Limited hepatitis B immunoglobulin with potent nucleos(t)ide analogue is a cost-effective prophylaxis against hepatitis B virus after liver transplantation. AU - Singer GA AU - Zielsdorf S AU - Fleetwood VA AU - Alvey N AU - Cohen E AU - Eswaran S AU - Shah N AU - Chan EY AU - Hertl M AU - Fayek SA PY - 2015 JO - Transplantation proceedings DO - 10.1016/j.transproceed.2014.11.029 UR - https://doi.org/10.1016/j.transproceed.2014.11.029 ER -
APA
GA, S., S, Z., VA, F., N, A., E, C., S, E., N, S., EY, C., M, H., & SA, F. (2015). Limited hepatitis B immunoglobulin with potent nucleos(t)ide analogue is a cost-effective prophylaxis against hepatitis B virus after liver transplantation.. Transplantation proceedings. https://doi.org/10.1016/j.transproceed.2014.11.029
Source records
- pubmed · retrieved 2026-09-27T08:49:13.553Z